Evidence map›Paper›PMID 41672994›Full record

ArticleNature communications2026

FidlTrack: high-fidelity structure-aware single particle tracking resolves intracellular molecular motion in organelles sensing APP processing.

Pierre Parutto, Yutong Yuan, Valentina Davì, Roger Pons-Lanau, Svenja Ebeling, Karnika Gupta, Francesca Bottanelli, Maria F Garcia-Parajo, Felix Campelo, Clemens F Kaminski and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pierre ParuttoUK Dementia Research Institute at the University of Cambridge, Cambridge, UK. pvp23@cam.ac.uk.ORCID 0000-0002-9866-407X
Yutong YuanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0009-0003-6456-9220
Valentina DavìUK Dementia Research Institute at the University of Cambridge, Cambridge, UK.
Roger Pons-LanauICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0001-6666-2435
Svenja EbelingInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Karnika GuptaUK Dementia Research Institute at the University of Cambridge, Cambridge, UK.
Francesca BottanelliInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0002-5360-1550
Maria F Garcia-ParajoICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Felix CampeloICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0002-0786-9548
Clemens F KaminskiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5194-0962
Joseph E Chambers *Cambridge Institute for Medical Research (CIMR), Department of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4675-0053
Jonathon Nixon-Abell *Cambridge Institute for Medical Research (CIMR), Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4169-0012
Edward AvezovUK Dementia Research Institute at the University of Cambridge, Cambridge, UK. ea347@cam.ac.uk.ORCID 0000-0002-2894-0585

Funding

Alzheimer's Society AS-PhD-19a-015EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology) Adv788546EC | EU Framework Programme for Research and Innovation H2020 | H2020 Excellent Science (H2020 Priority Excellent Science) Adv788546Fundación Cellex (Cellex Foundation) CEX2024-001490-SMinistry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2022-138282NB-I00Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2023-147711NB-100RCUK | Medical Research Council (MRC) MCMB MR/Y011813/1Wellcome Trust (Wellcome) 212892/Z/18/ZWellcome Trust (Wellcome) 218651/Z/19/ZWellcome Trust (Wellcome) 227745/Z/23/Z
6 · The paper itself

Abstract

Single Particle Tracking (SPT) is a powerful technique for elucidating the dynamic behaviours of macromolecules within live cells. However, SPT's application to subcellular environments is hampered by the error-proneness of tracking at high particle velocities and densities and the lack of tools to assess trajectory reliability. Here, we introduce FidlTrack, a methodology that benchmarks and improves SPT fidelity. It contains three modules: a parameter optimiser that uses synthetic ground truth SPT data to determine the fidelity-maximising experimental and tracking settings; Structure-aware tracking, that exploits the information provided by organelle structures to constrain particle tracking algorithms; And a tracking quality evaluator that detects, quantifies and removes error-prone ambiguous track segments. Together these tools allow the rational design of SPT experiments, resolving the motion in tight and convoluted organelles, and provide up to 2-fold enrichment in accurate data. We showcase FidlTrack's utility for reliably tracking proteins in the cytosol, mitochondria and endoplasmic reticulum (ER). Further, we demonstrate its efficacy by analysing ER protein dynamics at exit sites, resolving BACE1 amyloidogenic cleavage of the amyloid precursor protein and characterising the spatiotemporal binding dynamics of an ER-targeted intrabody. FidlTrack is provided as a universal open-access platform that can be incorporated into any SPT pipeline.

Indexed as

Amyloid beta-Protein PrecursorOrganellesSingle Molecule ImagingAlgorithmsAmyloid Precursor Protein SecretasesAnimalsCytosolEndoplasmic ReticulumHumansMitochondriaAmyloid beta-Protein PrecursorAmyloid Precursor Protein Secretases

Identifiers

PMID41672994
PMCPMC13004893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.